MedPath

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Phase 4
Completed
Conditions
Oral Leukoplakia
Registration Number
NCT00155337
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Detailed Description

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients with leukoplakia or erythroleukoplakia
Exclusion Criteria
  • oral cancers

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
End of 8 treatments
Secondary Outcome Measures
NameTimeMethod
Regression of lesions

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath